2026 US Rare Disease

Targeted Medical Insights' 2026 United States Rare Disease Benchmark Report. This report will benchmark 8 target Multiple Sclerosis organizations and provide data and insights for all customer facing personnel. Key Information Topics (KITs) include:

• Field Sales Deployment
• ​Field Based Managed Markets Including; Regional Accounts, National Accounts, Government Accounts, Payer Accounts, Corporate Accounts, Reimbursement Specialists, Specialty Pharmacy Accounts, Health System - Integrated Delivery Network Accounts, and others!
• Field Based Medical ​- Health Outcomes Liaisons, Managed Markets Medical Science Liaisons, Outcomes Specialists, and others!
• Organizational Structure with reporting relationships ​
• Key Roles, Strategies, and Responsibilities​

Price for the 2026 Rare Disease is $19,995.